Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
Total
Common Stock
Series A Preferred Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020   121,922,532 0      
Beginning balance at Dec. 31, 2020 $ 395,204,334 $ 121,923 $ 0 $ 504,112,442 $ (109,030,031) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares) [1]   1,332,321        
Stock options and warrants exercised, and vesting of restricted shares* [1] 14,220 $ 1,332   12,888    
Stock-based compensation 892,428     892,428    
Net loss (120,506,771)       (120,506,771)  
Ending balance (in shares) at Mar. 31, 2021   123,254,853 0      
Ending balance at Mar. 31, 2021 275,604,211 $ 123,255 $ 0 505,017,758 (229,536,802) 0
Beginning balance (in shares) at Dec. 31, 2021   151,915,455 0      
Beginning balance at Dec. 31, 2021 174,692,773 $ 151,916 $ 0 686,318,201 (510,374,844) (1,402,500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares) [1]   78,415        
Stock options and warrants exercised, and vesting of restricted shares* [1] (196,262) $ 78   (196,340)    
Stock-based compensation 2,350,293     2,350,293    
Net loss (22,054,535)       (22,054,535)  
Other comprehensive loss 1,402,500         1,402,500
Ending balance (in shares) at Mar. 31, 2022   151,993,870 0      
Ending balance at Mar. 31, 2022 $ 156,194,769 $ 151,994 $ 0 $ 688,472,154 $ (532,429,379) $ 0
[1] *Net of tax payments related to shares withheld for option exercises and vested stock.